Anteris Technologies Global Corp.: stock overview

AVRNASDAQHealthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Price

$4.99

November 20, 2026Market cap $486M

What Ploutos Investor adds for Anteris Technologies Global

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 2 fiscal years, from 2024
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

Anteris Technologies Global had revenue of $2.3M over the last 12 months and a net loss of $108M. It holds more cash than debt, by $217M. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 20, 2026.

Its SEC filings
Market cap
$486M
97.49M shares
P/E
–
Revenue, 12 months
$2.3M
-29.2% a year over 1 years
Net margin
-4,637.5%

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

2 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2024–2025 fiscal years
  • 202510-K
    Revenue$1.9M
  • 202410-K
    Revenue$2.7M

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 
$486M
Enterprise value 
$270M
P/E 
–
EV / EBIT 
–
EV / Revenue 
115.6
P/B 
2.2
FCF yield 
–
Earnings yield 
–

Profitability

Gross margin 
75.8%
Operating margin 
-4,880.4%
Net margin 
-4,637.5%
ROIC 
-59.0%
ROIC, 5-year average 
-98.7%
ROE 
-71.1%

Growth

Revenue, yearly change 
-29.2%
EPS, yearly change 
–
FCF, yearly change 
–
Revenue, average a year 
-29.2%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$217M
Total debt 
$16M
Of which operating leases 
$16M
Net cash 
$217M
Net debt / EBITDA 
–
Interest cover 
-615.2x
Current ratio 
12.45

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+2.4%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
Anteris Technologies Global Corp.
Exchange
NASDAQ
Industry (SIC)
3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
97.49M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do Anteris Technologies Global's filings show?

These are Anteris Technologies Global's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about AVR

Didn't find what you were looking for?

Ask us
What is AVR's market cap?

Anteris Technologies Global Corp.'s market cap is $486M, at a price of $4.99 on November 20, 2026 and 97.49M shares.

How much revenue does AVR have?

Anteris Technologies Global had revenue of $2.3M over the last 12 months. Over the last 1 years it changed by -29.2% a year on average.

Does AVR pay a dividend?

No. Anteris Technologies Global paid no regular dividend over the last 12 months.

Where do the figures come from?

From Anteris Technologies Global Corp.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.